N4 Pharma Share Discussion Threads

[pwal] 21/1/2025 17:32

Is this due sometime soon? Nanogenics has now submitted an application to the U.S. Food and Drug Administration ("FDA") to obtain orphan drug designation for its product ECP105, for the prevention of scarring following glaucoma surgery.

[simonrowan52] 17/1/2025 16:02

They certainly talking a good talk , maybe finally with some justification, but as Dr Smith says they have to back it up with something more solid to be taken seriously by the market.i.e income no more dilution

[pwal] 17/1/2025 15:24

Volumes high. I'm sure there's some FOMO before the announcement of the start of clinical trials. Final results I think are due around 22nd April.

[pwal] 16/1/2025 09:35

Does anyone know how long approval is expected to take?· The Company is awaiting ethics committee approval to build on these excellent in vitro data and begin an in vivo study in an appropriate animal model early in 2025 at the University of Queensland.

[pwal] 15/1/2025 08:32

Volume high already. What's up?Pump and dump or realisation of the potential?Not sure a placing is coming. All IMHO

[dplewis1] 14/1/2025 18:31

..a placing?

[pwal] 14/1/2025 15:38

Are people starting to realise what this will do once trials are announced?

[pwal] 14/1/2025 13:10

Come on N4P!

[pwal] 08/1/2025 11:35

It just needs an announcement of when trials are starting and, IMHO, this should take off.

[pwal] 08/1/2025 10:46

From todays RN:"I believe that Nuvec® will allow the Company to build a differentiated drug pipeline to drive long-term value and generate commercial progress through platform licensing deals and partnerships in the near term."

[pwal] 04/1/2025 08:42

Let's have an announcement next week please.

[pwal] 30/12/2024 13:17

An announcement of in vitro trials starting should send the share price much higher. Primed and ready to go IMHO

[pwal] 17/12/2024 11:36

· The Company is awaiting ethics committee approval to build on these excellent in vitro data and begin an in vivo study in an appropriate animal model early in 2025 at the University of Queensland.Can't wait!

[pwal] 06/12/2024 15:36

Well who knew.

[earwacks] 06/12/2024 15:11

We’re making plans for Nigel

[pwal] 06/12/2024 13:42

Someone is having a laugh.

[dplewis1] 06/12/2024 10:58

2m shares getting dumped by someone correctly deducing that patent applications do not equal revenue

[pwal] 04/12/2024 15:28

Oh come on! Show some interest! The possibilities are endless! IMHO.

[pwal] 04/12/2024 08:39

More patents.

[mortimer7] 28/11/2024 08:23

3 year options to vest at 0.75p!
Too low - wrong message.

[pwal] 23/11/2024 09:37

Tweet:The @humancellatlas is transforming our understanding of health and disease. With newly uncovered cell types, including those linked to inflammation in #IBD, advanced therapies targeting specific cells such as Nuvec®, will be more in demand: bbc.co.uk/news/articles/... @BBCNews #N4P

[pwal] 20/11/2024 10:00

What news from the show?

[mello2024] 12/11/2024 21:24

Just to let shareholders and prospective investors know that N4 Pharma will be presenting at Mello's 10-year anniversary show on Tuesday 19th November 2024 9am - 7pm.

The Budget is out, Mello is in! To celebrate our 10 Year Anniversary, we have created a two-day investor conference that will include top quality keynote speakers including but not limited to Peter Pereira Gray, Paul Hill, Ben Rogoff, Rosemary Banyard and Gervais Williams. Also featuring panel sessions such as our popular Mello BASH (Buy, Avoid, Sell, Hold) with professional investors and analysts such as Leon Boros, Mark Simpson and Paul Scott. There will be over 40 exhibiting companies and over 60 presentations from companies such as The Property Franchise Group, Time Finance, Brave Bison, Mortgage Advice Bureau, Aeorema and many more! Get 50% off your ticket with code MMTADVFN50. Tickets are still available:

[pwal] 12/11/2024 12:27

The price has moved because of the large spread. Hopefully that will close up and we can see a real rise.